{"pmid":32434818,"title":"Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.","text":["Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.","Ann Rheum Dis","Monti, Sara","Montecucco, Carlomaurizio","32434818"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Montecucco, Carlomaurizio"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434818","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217800","keywords":["antirheumatic agents","arthritis, rheumatoid","cardiovascular diseases"],"weight":0,"_version_":1667521393528406017,"score":9.490897,"similar":[{"pmid":32434823,"title":"Rheumatic diseases in intensive care unit patients with COVID-19.","text":["Rheumatic diseases in intensive care unit patients with COVID-19.","Ann Rheum Dis","Moiseev, Sergey","Avdeev, Sergey","Brovko, Michail","Yavorovskiy, Andrey","Novikov, Pavel I","Umbetova, Karina","Akulkina, Larisa","Tsareva, Natal'ya","Fomin, Victor","32434823"],"journal":"Ann Rheum Dis","authors":["Moiseev, Sergey","Avdeev, Sergey","Brovko, Michail","Yavorovskiy, Andrey","Novikov, Pavel I","Umbetova, Karina","Akulkina, Larisa","Tsareva, Natal'ya","Fomin, Victor"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434823","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217676","keywords":["antirheumatic agents","autoimmune diseases","cytokines"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667521393624875009,"score":70.67593},{"pmid":32424028,"title":"Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?","text":["Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?","Ann Rheum Dis","Erre, Gian Luca","Ferraccioli, Edoardo Sean","Piga, Matteo","Mangoni, Arduino","Passiu, Giuseppe","Gremese, Elisa","Ferraccioli, Gianfranco","32424028"],"journal":"Ann Rheum Dis","authors":["Erre, Gian Luca","Ferraccioli, Edoardo Sean","Piga, Matteo","Mangoni, Arduino","Passiu, Giuseppe","Gremese, Elisa","Ferraccioli, Gianfranco"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32424028","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217828","keywords":["antirheumatic agents","cardiovascular diseases","hydroxychloroquine"],"topics":["Treatment"],"weight":1,"_version_":1667352728878186496,"score":67.85608},{"pmid":32299795,"title":"Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","text":["Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","Ann Rheum Dis","Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas","32299795"],"journal":"Ann Rheum Dis","authors":["Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299795","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1136/annrheumdis-2020-217509","keywords":["antirheumatic agents","autoimmune diseases","biological therapy","communicable diseases, imported","glucocorticoids"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666138494849777664,"score":61.736374},{"pmid":32340978,"title":"The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi et al.","text":["The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi et al.","Ann Rheum Dis","Monti, Sara","Montecucco, Carlomaurizio","32340978"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Montecucco, Carlomaurizio"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340978","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/annrheumdis-2020-217545","keywords":["arthritis, rheumatoid","immune system diseases","inflammation"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"weight":0,"_version_":1666138495838584835,"score":57.861225},{"pmid":32241793,"title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.","text":["Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.","Ann Rheum Dis","Monti, Sara","Balduzzi, Silvia","Delvino, Paolo","Bellis, Elisa","Quadrelli, Verdiana Serena","Montecucco, Carlomaurizio","32241793"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Balduzzi, Silvia","Delvino, Paolo","Bellis, Elisa","Quadrelli, Verdiana Serena","Montecucco, Carlomaurizio"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241793","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1136/annrheumdis-2020-217424","keywords":["antirheumatic agents","arthritis, rheumatoid","biological therapy","spondylitis, ankylosing"],"link_comment_in":"32299844","topics":["Treatment"],"weight":1,"_version_":1666138492152840194,"score":55.095}]}